Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuichiro Doi

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Surgery|August 30, 2003
Increased PDX-1 expression is associated with outcome in patients with pancreatic cancerMasayuki Koizumi, Ryuichiro Doi, Eiji Toyoda, et al.
Pancreas|February 17, 2005
Analysis of E-, N-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell linesEiji Toyoda, Ryuichiro Doi, Masayuki Koizumi, et al.
Neoplasia (New York, N.Y.)|January 16, 2007
Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cellsMeiko Takahashi, Takanobu Yoshimoto, Masayuki Shimoda, et al.
Endocrine Journal|December 6, 2006
A case of secretin-responsive insulinoma with low serum C-peptide levelsJunji Fujikura, Kiminori Hosoda, Michio Noguchi, et al.
Nuclear Medicine and Biology|May 25, 2006
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumorsHirofumi Hanaoka, Takahiro Mukai, Hirokazu Tamamura, et al.
Clinical Endocrinology|April 28, 2011
Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in JapanMichiya Masue, Hironori Nishibori, Seisuke Fukuyama, et al.
Hepato-Gastroenterology|November 17, 2011
Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a caseToshihiko Masui, Ryuichiro Doi, Kohei Ogawa, et al.
Surgery|July 9, 2005
Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancerTomohiko Mori, Ryuichiro Doi, Eiji Toyoda, et al.
World Journal of Surgery|January 21, 2006
Clinical significance of focal adhesion kinase in resectable pancreatic cancerKenichiro Furuyama, Ryuichiro Doi, Tomohiko Mori, et al.
Surgery|August 10, 2004
Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cellsDaisuke Ito, Koji Fujimoto, Ryuichiro Doi, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Surgery|August 30, 2003
Increased PDX-1 expression is associated with outcome in patients with pancreatic cancerMasayuki Koizumi, Ryuichiro Doi, Eiji Toyoda, et al.
Pancreas|February 17, 2005
Analysis of E-, N-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell linesEiji Toyoda, Ryuichiro Doi, Masayuki Koizumi, et al.
Neoplasia (New York, N.Y.)|January 16, 2007
Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cellsMeiko Takahashi, Takanobu Yoshimoto, Masayuki Shimoda, et al.
Endocrine Journal|December 6, 2006
A case of secretin-responsive insulinoma with low serum C-peptide levelsJunji Fujikura, Kiminori Hosoda, Michio Noguchi, et al.
Nuclear Medicine and Biology|May 25, 2006
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumorsHirofumi Hanaoka, Takahiro Mukai, Hirokazu Tamamura, et al.
Clinical Endocrinology|April 28, 2011
Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in JapanMichiya Masue, Hironori Nishibori, Seisuke Fukuyama, et al.
Hepato-Gastroenterology|November 17, 2011
Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a caseToshihiko Masui, Ryuichiro Doi, Kohei Ogawa, et al.
Surgery|July 9, 2005
Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancerTomohiko Mori, Ryuichiro Doi, Eiji Toyoda, et al.
World Journal of Surgery|January 21, 2006
Clinical significance of focal adhesion kinase in resectable pancreatic cancerKenichiro Furuyama, Ryuichiro Doi, Tomohiko Mori, et al.
Surgery|August 10, 2004
Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cellsDaisuke Ito, Koji Fujimoto, Ryuichiro Doi, et al.
Pageof 12